RxDoctor Payments Data

Lauren Morris, PA

Physician Assistant · Charlotte, NCNPI 1730476201

Payments from drug & device makers

$1,817in general payments, 2019–2025

Across 59 payments — averaging $30.79 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Boston Scientific$405
  • Pfizer$255
  • Medtronic$210
  • Irhythm Technologies, Inc.$180
  • AstraZeneca$176
  • Sanofi-aventis U.S. LLC$144
  • plus $446 from 11 others

What the payments were for

  • Food & beverage$1,817100%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$1,817 in reported general payments places this provider in the 75th percentile of 7,441 physician assistant providers in North Carolina.

See all physician assistant providers in North Carolina

Medicare billing

Part B allowed, 2024
$54,728
Medicare patients
341
Services billed
699

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
EliquisApixaban277$236,022
EntrestoSacubitril/Valsartan86$99,315
Repatha SureclickEvolocumab103$91,547
XareltoRivaroxaban77$72,679
FarxigaDapagliflozin Propanediol73$57,938
JardianceEmpagliflozin64$50,738
Praluent PenAlirocumab30$18,515
BrilintaTicagrelor18$12,186
Repatha SyringeEvolocumab11$7,357
Ranolazine ErRanolazine80$6,571
Ezetimibe237$4,891
Atorvastatin Calcium426$4,307
Isosorbide Mononitrate ErIsosorbide Mononitrate160$2,895
Metoprolol Succinate280$2,835
Enoxaparin Sodium36$1,858

Paid to pharmacies, not to this prescriber.

Companies that both paid and supply prescribed drugs

These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.

CompanyPaid to this providerPart D cost of their drugs
PfizerEliquis$255$236,022277 claims
NovartisEntresto$20$99,31586 claims
Johnson & JohnsonXarelto$76$72,67977 claims
AstraZenecaFarxiga, Brilinta$176$70,12491 claims

Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 75th percentile of 7,441 physician assistant providers in North Carolina.

Other physician assistant in Charlotte

See the full list for North Carolina

Where these figures come from

Is this you, or does something look wrong? →